Friday, January 12, 2024 5:32:15 PM
from end of 2021...
"3) After discussions with the OTC, and determining they will not accept independent SEC filings in order to restore NanoLogix to tradable Pink Sheet status, we will begin providing OTC with financials, and accept the burden of a $10,000 yearly fee. This is required to restore the Company to tradable status.
An Exciting and Vital Development
We have received a proposal from a large and very well respected research and development corporation titled for "Development of a Rapid Viral Assay (RVA) Suitable for Detection of COVID-19 and Other Viruses". This work will be accomplished utilizing live virus samples of multiple strains of COVID-19. Our initial portion of the development costs for the proposal is roughly $500,000. We have begun raising that amount through the use of a mechanism offering a small net revenue interest percentage of potential RVA sales. We have already raised $150,000 from interested medical groups through use of that mechanism, and intend to raise the balance with no sale or dilution of stock.
They couldn't use some of that money to get back to the trading status they had ? And if they raised that $150,000.....where did it go ?
FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM